Arch Therapeutics, Inc. (OTCMKTS:ARTH) Short Interest Update

Arch Therapeutics, Inc. (OTCMKTS:ARTH) was the recipient of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 6,600 shares, a decrease of 55.7% from the March 31st total of 14,900 shares. Currently, 0.1% of the company’s stock are sold short. Based on an average daily trading volume, of 11,700 shares, the days-to-cover ratio is currently 0.6 days.

Arch Therapeutics Price Performance

The stock has a fifty day moving average of $0.20 and a 200 day moving average of $0.23. Arch Therapeutics has a 1-year low of $0.16 and a 1-year high of $1.57.

About Arch Therapeutics

Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.